바로가기메뉴

본문 바로가기 주메뉴 바로가기

Effect of Beraprost Sodium in Patients with Chronic Obstructive Pulmonary Disease

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2004, v.57 no.4, pp.320-328











  • Downloaded
  • Viewed

Abstract

keywords
Beraprost sodium, COPD, Pulmonary hypertension.만성폐쇄성폐질환 환자에서 Beraprost sodium의 효과에 대한 연구: 이중맹검 무작위 임상시험울산대학교 의과대학 내과학 교실, 중앙대학교 의과대학 내과학교실1이상도, 서광원, 이정연, 허진원, 최익수, 박재선, 심태선, 오연목, 박인원1, 류왕성1, 최병휘1Effect of Beraprost Sodium in Patients with Chronic Ob

Reference

1.

(Dis1976) State of the art:Chronic cor pulmonale,

2.

(1984) Pulmonary hypertensive diseases,

3.

(1999) Predictive factors of hospitalization for acute exacerbation in a Series of 64 patients with chronic obstructive pulmonary disease,

4.

(1972) Patterns of cardiovascular dysfunction in chronic obstructive lung disease,

5.

(1981) Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease,

6.

(1985) Site of hypoxic pulmonary vasoconstriction,

7.

(1983) The structure and function of the pulmonary vasculature in mild chronic obstructive pulmonary disease,

8.

(1980) Morphologic changes in the muscular pulmonary arteries:relationship to cigarette smoking,airway disease,and emphysema,

9.

Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease,

10.

(1981) Report of the Medical Research Council Working Party,

11.

(1985) Improved hemodynamics but reduced arterial blood oxygenation,at rest and during exercise after long term oral prazocin therapy in chronic cor pulmonale,

12.

(1989) Nifedipine reduces pulmonary pressure and vasodilator tone during short-but not long-term treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease,

13.

(1997) Orally active prostacyclin analogue in primary pulmonary hypertension,

14.

(1999) Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension,

15.

(2002) Beraprost:a review of its pharmacology and therapeutic efficacy in treatment of peripheral arterial disease and pulmonary arterial hypertension,

16.

(2001) Long term treatment of pulmonary arterial hypertension with beraprost,an oral prostacyclin analogue,

17.

(1991) Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease,

18.

(2000) Deletion polymorphisms in the angiotensin converting enzyme gene are associated with pulmonary hypertension evoked by exercise challenge in patients with chronic obstructive pulmonary disease,

19.

(1998) Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease,

20.

(1997) Interpreting small differences in functional status: The Six Minute Walk test in chronic lung disease patients,

21.

(1999) Prospective randomized trial comparing bilateral lung volume reduction surgery to pulmonary rehabilitation in severe chronic obstructive pulmonary disease,

22.

(1997) Combined inhalation of nitric oxide and oxygen in chronic obstructive pulmonary disease,

23.

(1993) Felodipine improves pulmonary hemodynamics in chronic obstructive pulmonary disease,

24.

(1984) Noninvasive estimation of right ventricular systolic pressure by doppler ultrasound in patients with tricuspid regurgitation,

25.

Doppler echocardiographic evaluation of pulmonary artery pressure in chronic obstructive pulmonary disease Working group on Noninvasjre Fraluation of pulmonary artery pressure European office of the world health orqanization,

26.

(2002) ATS statement: guidelines for the six-minute walk test. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories,

27.

(2000) Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension.comparison with cardiopulmonary exercise testing,

Tuberculosis & Respiratory Diseases